- Patient Experience: The biggest thing shaping patient experience is that patient experience now matters, due to satisfaction scores and financial penalties among the largest drivers.
- The Affordable Care Act: Insurance coverage expansion for millions of Americans, particularly those with pre-existing conditions has provided new opportunities for patients to seek care, but the ACA still faces challenges from a newly empowered GOP Congress and Supreme Court cases.
- Electronic Health Records Adoption: More doctors’ offices and hospitals have implemented their EHRs and are learning to use them, offering patients fewer opportunities to give the same demographic information over and over again, although multiple portal sign ins may fill the time.
- Access to Data: The number of pledgee organizations to the ONC’s Blue Button program continues to grow and Meaningful Use requirements that patients have the right to view, download, and transmit their data improves access to medical records and claims data.
- Contributing to Data: Whether you wear a wearable activity tracker on your bracelet, belt, or bra, patient generated health data (PGHD) is expanding the scope of what is considered health data by quantifying the 99% of our lives spent outside the doctor’s office.
- Framework for Big Data: Lots of “little” PGHD quickly becomes Big Data with the potential to revolutionize research, creating an active, adaptive learning health system once there is greater consensus on issues of privacy, security, and consent.
- Personalized Medicine: The realization that Big Data and genomic-based medicine are interdependent, each needed to facilitate personalized treatment delivering precision therapeutics trained on biomarkers and individualized care based on analytics.
- Defining interoperability: All this data stays data, rather than knowledge, and actionable information unless it allows care to be connected seamlessly, following the patient in a physician and practice-agnostic manner rather than captured in hospital system silos.
- Telemedicine and Retail Clinics: Bringing care to the patients whether around the corner at the drugstore, an urgent clinic, or through video consult, provides substance to concepts like access and convenience.
- Cost information: The advent of higher co-pays, deductibles, directly paid premiums, and shifts in the conversation to value in healthcare creates the demand for transparency in the cost and price of tests, procedures, and services.
- Expanding roles of nurses, PAs, NPs: As the medical complexity of patients, as well as the recognition of the behavioral, literacy, and other challenges creating barriers to patients co-developing, understanding, and implementing prevention and care plans and achieving goals for which medical practices are accountable, the role of non-physician clinicians will continue to expand.
- Online Patient Platforms: Online platforms and communities provide 24/7 information, support, and experience comparisons heretofore found only approximated in live support groups or phone hotlines.
- Research & Drug Development: Patient advocacy organizations are taking a more proactive role in developing research agenda, pulling together research consortia, funding targeted drug development through venture philanthropy models, and redefining risk/benefit and other determinants of the drug approval process.
- The Patient Voice: New positions in federal agencies, on medical boards and committees, and in hospital councils mark the transition from patients simply having a voice, but having a vote in essential matters shaping healthcare.
- Relationship with Doctors: The doctor-patient relationship is stressed, stretched, and frayed by all of the above, but more important than ever for the integration of scientific, clinical, and social information into expert counsel, deft surgical technique, and partnership in healing.
Archive for the ‘HIT’ category
Help Me Spread the Word! Innovative Patient-Controlled Registry Invites Liver Patients to Engage
Today (April 5, 2013) I am honored to present at the 3rd Annual CanLiv Research Symposium on Hepatobiliary Cancers, on the topic of “Putting Patients at the Center of Drug Discovery”. CanLiv is a vibrant and vital organization in the liver community, founded by Dr. Melanie B Thomas, Associate Professor, Associate Clinical Director of the Hollings Cancer Center and Grace E. DeWolff Professor of Medical Oncology at the Medical University of South Carolina, to support patients with liver cancer and catalyze new research.
Liver cancer or hepatocellular carcinoma (HCC) is the 5th most common cancer in the world and the 3rd leading cause of cancer death. Unlike many other cancers in the U.S. liver cancer rates are rising. Yet there is only one FDA-approved medication for liver cancer, sorafenib (nexavar), although for some patients surgical or radiation therapies are appropriate. Clinicaltrials.gov indicates that there are 741 liver cancer studies currently recruiting patients. One of the largest limiting factors for finding additional treatment alternatives are the low number of liver cancer patients who are participating in clinical research. Only 3-4% of cancer patients and 1-2% of liver patients participate in clinical trials.
I’d like your help in transforming how patients are involved in clinical research. I want to see participation in clinical research, as agenda-setters, outcome-selectors, study-designers, as well as subjects, become the norm for patients in liver disease ( and all conditions!). One of the new tools to help do this is Registries for All (Reg4All), www.reg4all.org , a novel patient-controlled online platform for sharing health information with researchers and each other developed by respected non-profit patient advocacy organization Genetic Alliance . It has already won awards and started to hit tech publications. http://www.technologyreview.com/news/512456/new-disease-registry-gives-patients-some-privacy/
Most people think that registries are only for bridal or baby shower gifts, but registries, repositories for identified and de-identified health information, have the potential to accelerate the research process.
Reg4All is unique because:
¨ Permission to search, discover, access, use and share any data in the registry is 100% participant-controlled
¨ For all individuals – healthy and all conditions (most registries are siloed and of limited use to someone like me with multiple conditions)
¨ Entering information is fun, instead of tedious due to a gamified survey powered by Traitwise®
¨ Each participant controls his or her information through dynamic granular sharing settings – who, how, when and if data is shared thanks to PrivateAccess™ technology
¨ With the individual’s permission, this data is searchable by researchers in real-time through RecruitSource
Liver cancer, and liver research in general is in need of innovation. My vision is that it can be transformed from the inside out by patients who are active partners in driving that innovation. Reg4All only realizes its potential if patients embrace it.
¨ Empowering liver patients by valuing patient-generated health data
¨ Engaging liver patients by providing real-time feedback on comparison to others
¨ Entrusting patients with control over if, when, how, and with whom their health data is shared
¨ Representing the whole person rather than individual conditions and disease states (GI, Liver, Immune, Cancer, Biomarkers)
¨ Enriching and enlarging pool of patients to accelerate recruitment through community participation
¨ Reducing frustration and complexity of finding trials
Please help spread the word, particularly to patient advocates, liver and liver cancer patients. Mention Reg4All in all of your communication vehicles Friday and moving forward.
Liver pts take control of your health data to speed health breakthroughs, B discovered 4 clinical trials. www.Reg4All.org #Reg4All #CanLiv
Friday April 5th patients and family members living with liver disease are invited to try Registries for All (Reg4All) to share their health information, discover clinical research opportunities, and speed innovation in drug discovery for liver diseases.
Reg4All is unique in 2 ways:
1. It operates across all health and disease conditions. (So more likely to identify research opportunities from correlations between IBD, CF, liver disease, and liver cancers)
2. Each participant controls everything about their information– what they store, what if anything they share, with whom they share, for what purposes that information may be used– everything.
Innovative Patient-Controlled Registry Invites Liver Patients to Engage
Speeding up the pace of innovation and new drug development is vital for individuals with liver disease.
Research seeks to discover safer, more effective, or easier to tolerate treatments and therapies – therapies that may improve prolong or save your life or patients like you.
Research can’t happen without patients willing to learn more about clinical studies and choosing to participate in studies that are right for them.
As a liver transplant survivor and the former president of the American Liver Foundation, I am excited to partner with Genetic Alliance, a national non-profit advocacy association, to promote a novel solution that makes finding and being found for a clinical trial easier — Registries for All (Reg4All).
If you or a loved one has liver cancer, cirrhosis, hepatitis, and other forms of liver disease, please explore Reg4All so we can all help each other.
Reg4All features TrialsFinder which provides a new, effective way to match individuals who are willing to participate in research with researchers looking for them. Our top priority is helping you to find research projects that are useful you, making it easy for researchers to find you, while allowing you to control how, when, and if your information is shared.
Please join us in this by visiting www.Reg4all.org
I have to admit, I was like Ralphie in the movie A Christmas Story, when he finally received his Little Orphan Annie decoder ring in the mail after a long wait and much anticipation, only to find out that the secret message was to “Drink your Ovaltine”.
Such was my let down when after finding out, only through passing comments by one of the physicians I am friends with at the hospital where I receive most of my care, that there was indeed a patient portal at the institution [Comment 1: if you have a patient portal please tell patients about it] and finally receiving a PIN number to gain entry, and working with the helpline to find out that I must enter my name in ALL CAPS because that is how it is in my patient record at the hospital [Comment 2: random case sensitivity not mentioned in the instructions, unnecessary barrier to use] I accessed my patient portal to find – NOTHING!
Ok, almost nothing. After being a patient at this institution for 6 years, seeing primary care, GI, transplant, having multiple labs, procedures, imaging, and being an inpatient there was the following information available to me:
- Four (4!) values under general health – 1 blood pressure reading from December 2012 and 3 lipid values from June 2008
- My medications list
- My immunizations
That’s it! Hello, where’s my data? [Comment 3: The whole point of a patient portal is to have access to all the information about me (including the notes, see OpenNotes project ) in the EMR of the hospital and associated practices.] That not just my hope or opinion. When I finally got my hands on a marketing brochure for the portal they describe themselves as, “your direct link, via your personal computer, to the electronic health record your doctor creates and maintains for you.” It further states that, “Your entire paper patient record file is now stored digitally in a safe, secure environment.” If my doctors only have 4 values, a list of medications, and immunization records upon which to make clinical decisions about me then I am in big trouble.
As for other features – request an appointment and request a referral are really just secure emails that the fine print mentions may take 2-3 days to be returned. I might as well just call. Actual appointment scheduling, alerts to upcoming appointments and allowing me to fill out the forms in advance of the appointment would be worth my time and very helpful to both patient and provider efficiency. The renew prescription feature is limited, certainly nothing to make me give up the auto-refill and auto-renew offerings from CVS/Caremark’s website.
The final indignity is the request test results feature – JUST SEND THEM! Why should I have to specifically recall and request each lab, procedure, and test result? Also, I couldn’t even if I wanted to because only one of my doctors is listed. Indeed, Meaningful Use objectives include providing patients with timely electronic access to health information within 4 business days of that information being available to the provider. Start with uploading the clinical summaries if that’s all you can handle right now, but 4 values over 6 years of data is inexcusable.
The Frequently Asked Questions section (my real questions are truly just WTF and why did you bother?) explains that this portal is not intended to be a PHR. The option is given to upload this information into my Microsoft HealthVault account. Not much use if there is nothing to upload.
The FAQs also say, “no”, literally, to being able to view, share, or help manage your family members’ records. [Comment 4: Access by parents, children of seniors, or other caregivers is one of the top reasons that people would derive value in using a patient portal] The marketing materials, however, state that, “you may choose to share your lab results and other information with a family member you want to help manage your care.” You just can’t do it here. Well you can if you give your caregiver your ID and password, but they don’t mention that.
The rest of the site is health education and risk assessment tools and information on the various hospitals in the system. [Comment 5: Risk assessment tools are more useful if you populate the risk factors from my record and I would be more willing to look through your propaganda if you had met my needs first].
In sum, I have seldom in my life experienced such great disappointment. This portal is more like Sarah Palin’s Bridge to Nowhere. I know the technology, the policies, and the incentives exist to create and operate a useful patient portal. My institution just chose not to. This says to me that activating, engaging, or empowering me is not important to them. Fortunately, I am activated, engaged, and empowered enough to go elsewhere.
Good morning, Chicago! Looks like a great day to start something new.
Today is the launch of the American Liver Foundation’s Innovation Council. (@ALF_USA) Chaired by Dr. Danny Sands (@Dzsands) (@S4PM), Director of Healthcare Business Transformation at Cisco, and Dr. Nancy Reau, Assistant Professor of Medicine at the University of Chicago, the ALF Innovation Council is intended to bring together creative minds from across silos in healthcare to help us solve key problems facing liver disease patients and their families.
The program will also feature a panel of patients discussing their various experiences with liver disease and a presentation of the state of liver disease and treatment today.
If you are reading this blog post, it is likely that you have been unable to join us in person, but we’d still love your input.
Please comment on the four questions below or tweet us this afternoon (we start at 1pm CT) using the hashtag #ALF_IC. Many thanks to the Innovator companies who are helping to spark our imaginations.
Step One: Detection/Diagnosis : Moderator Nancy Reau, MD
Key Issue/Question: How can we expand the number of patients in rural and underserved communities accurately diagnosed with liver disease?
Innovation Example: OraSure Rapid Test (rapid diagnostic test for HIV and HCV) @OraSureTech
Step Two: Newly Diagnosed/Treatment Selection: Moderator Danny Sands, MD
Key Issue/Question: How can we accelerate the understanding of a patient and their family of their diagnosed condition and how they are going to navigate an increasingly complex set of options?
Innovation Example: Inquisit Health (peer-to-peer web platform) @InquisitHealth
Step Three: In-Treatment: Moderator John Kontor, MD
Key Issue/Question: How can we optimize therapies by helping patients overcome barriers to adherence?
Innovation Example: Ginger io (smartphone/SMS/adherence and behavior feedback program)
Step Four: Survivorship: Donna Cryer, JD @DCpatient
Key Issue/Question: What are the best long term outcomes for liver patients and how do we achieve them?
Innovation Example: Galileo Analytics (data mining and visualization tool)
In last week’s post, New Year’s Resolutions for E-patients, I used the term research literacy. Go ahead. Google it. “research literacy” I’ll wait.
What did you find? Nothing. Exactly. Your heard it here first folks. A new concept for a new year.
As a long-time Star Trek Fan (Original, Next Generation, Deep Space Nine, even-numbered movies) I had believed that space was the final frontier. In patient engagement, however, I have come to believe that in fact the final frontier is research.
From Patients Like Me impromptu lithium studies to reviewing grants for the Patient Centered Outcomes Research Institute (PCORI), patients are acting on pent-up desires to engage in research as other than mere subjects.
Although there is greater acceptance by physician, health system, and academic communities that patient engagement is desirable and likely to improve outcomes on an individual and population health basis, there still exists skepticism to the point of incredulousness that patients could, let alone, should, have a role in research other than as subjects.
Patient engagement for a large segment of the healthcare system equates to compliance, or if they are being politically correct, adherence. Engagement, to them, means participation to the degree that we are able to do what the doctor has told us to do correctly. However, just as children do not stop growing at that adorable toddler phase, patients are maturing as well in the types of questions we ask and the roles we would assume.
One of those roles for many patients, particularly those with chronic and/or rare diseases, is the development of research questions, queries about analysis and applicability of existing data or recommendations for studies that answer questions based on their own experiences and areas of emphasis.
There are numerous instances of patients or parents/caregivers starting foundations or companies for that matter to jumpstart the discovery and development of cures or even advocacy organizations like Faster Cures which has a robust track record of innovation and collaboration, but aside from the work of a limited number of advocacy organizations confined primarily to specific disease states, (Advocate Institute), no one teaches the average patient how research is conducted or provides an opportunity to become a researcher.
A great deal of the resistance by the research community to patient engagement in this arena is the inability of most patients to “speak the language”. Just as in Stage 1 of Meaningful Use patients were dismissed when they weren’t able to answer questions such as “Are you in favor of meta-tagging of data?”, patients without backgrounds in biostatistics, study design, and epidemiology are considered to have nothing to offer to the field.
Learning the lessons of Stage 1 Meaningful Use of Health Information Technology, which has progressed to a burgeoning consumer engagement phase and active mhealth community, I propose a two-fold solution:
(1) Patients and caregivers would be well served to gain research literacy – an understanding of the mathematical and scientific terminology and tools fostering the ability to interpret and apply medical information and the clinical study process that produces that information. (If that sounds daunting or unreasonable, figure that if nothing else, the ability to differentiate absolute from relative risk will stand you in good stead every time you read the morning paper and see a screaming headline that states drinking coffee increases your risk of death 800%)
(2) Researchers need to develop the right questions to facilitate the translation by patients of their experience into research terms and frameworks. Just as “Are you in favor of meta-tagging of data?” evolved into “What do you want an electronic medical record to do?”, the clinical research community would benefit (in better targeted studies, faster recruitment, better retention, and increased adoption of interventions) from meeting patients where they are.
PCORI is charged specifically with identifying and developing mechanisms for patient engagement in comparative effectiveness research. It is potentially transformational in defining research in a manner that is “informed by the perspectives, interests and values of patients throughout the research process, from the selection of research questions to the dissemination of research results.” It is my hope that PCORI and others begin providing patients with the training and tools to make high-quality contributions to research and motivation to physicians to set another chair at the table.